Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Aethlon Medical (AEMD) Interest Expenses (2016 - 2021)

Aethlon Medical filings provide 11 years of Interest Expenses readings, the most recent being $125.0 for Q2 2021.

  • On a quarterly basis, Interest Expenses fell 82.83% to $125.0 in Q2 2021 year-over-year; TTM through Mar 2022 was $125.0, a 92.09% decrease, with the full-year FY2025 number at $10109.0, down 46.69% from a year prior.
  • Interest Expenses hit $125.0 in Q2 2021 for Aethlon Medical, up from $50.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $189022.0 in Q1 2017 to a low of $21.0 in Q3 2019.
  • Median Interest Expenses over the past 5 years was $55103.0 (2018), compared with a mean of $51690.2.
  • Biggest five-year swings in Interest Expenses: plummeted 99.96% in 2019 and later soared 536.51% in 2020.
  • Aethlon Medical's Interest Expenses stood at $55912.0 in 2017, then decreased by 1.44% to $55107.0 in 2018, then tumbled by 99.77% to $126.0 in 2019, then soared by 536.51% to $802.0 in 2020, then crashed by 84.41% to $125.0 in 2021.
  • The last three reported values for Interest Expenses were $125.0 (Q2 2021), $50.0 (Q1 2021), and $802.0 (Q4 2020) per Business Quant data.